Last patient screened

Drawing showing lesions in brain stem and spinal cord.

Drawing showing lesions in brain stem and spinal cord.

GCT team is pleased to announce the end of subject screening for a relapsing-remitting multiple sclerosis trial in Russia.

In total 243 patients were screened by 21 participating sites in 9-month period.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2018 Global Clinical Trials, LLC

All rights reserved.